This study found that compared with the control group, the expression of p-PI3K, p-Akt, and p-mTOR increased in the diabetic group had significantly decreased after GLP treatment, indicating that GLP may improve diabetic nephropathy by inhibiting the PI3k/Akt/mTOR signaling pathway. This evidence concerns the gene MTOR and diabetic kidney disease.